Pulmonary Hypertension

Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Pulmonary arterial hypertension targeted for new treatment by Sheffield scientists - EurekAlert Bellerophon Announces Positive Initial Data from Acute Hemodynamic Dose Escalation Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease - BioSpace Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Posted: 27 Nov 2019 08:00 AM PST New preclinical data supports the positive effects of Liminal Biosciences 's lead candidate,  PBI-4050 , in reducing pulmonary hypertension and the abnormal enlargement of the heart's right ventricle muscle. ...

While It's Difficult to Share, Here Is My PH Diagnosis Story - Pulmonary Hypertension News While It's Difficult to Share, Here Is My PH Diagnosis Story - Pulmonary Hypertension News Posted: 15 Nov 2019 12:00 AM PST November is Pulmonary Hypertension Awareness Month , a good time to share a little more about my journey with y'all. My hope is that you will tell your stories and generate awareness about pulmonary hypertension (PH) within your communities. I was diagnosed in 2005. Because of my nursing background , I had brushed off my symptoms. I remember thinking that I had eaten too much and gained weight over the holidays. But I knew something was wrong. I was grocery shopping one afternoon after work when I started to feel "off." Holding on to my cart, I was dizzy and short of breath. It was strange because I walked and jogged several times a week, and I attended aerobics c...

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival - TCTMD Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival - TCTMD Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Pulmonary arterial hypertension targeted for new treatment by Sheffield scientists - EurekAlert MitraClip Cases Often Involve Risky Pulmonary HTN - MedPage Today Actelion Pulls Requests to Treat Inoperable CTEPH with Opsumit, Will Gather More Data - Pulmonary Hypertension News Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival - TCTMD Posted: 26 Nov 2019 11:47 AM PST The analysis lacks the nuance, one expert says, to tease out exactly which patients with pre-interventional PH will fare poorly. LONDON, England—Patients with pulmonary hypertension (PH) undergoing TAVR for severe symptomatic aortic ste...

Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Liminal Biosciences's PBI-4050 Reduces Pulmonary Hypertension, Preclinical Data Show - Pulmonary Hypertension News Posted: 27 Nov 2019 08:00 AM PST New preclinical data supports the positive effects of Liminal Biosciences 's lead candidate,  PBI-4050 , in reducing pulmonary hypertension and the abnormal enlargement of the heart's right ventricle muscle. The company presented its latest data on two posters at the American Heart Association 2019 conference, held recently in Philadelphia. The posters are titled " PBI-4050 Reduces Angio-proliferative Pulmonary Arterial Hypertension: Decreased Human Pulmonary Artery Smooth Muscle Cell Proliferation and Microvascular Endothelial Cell Endoplasmic Reticulum Stress, " and " Transcriptomics of Lung Molecular Remo...